Market Cap | ₹126Cr |
ROE | 15.07% |
P/E Ratio(TTM) | 15.67 |
EPS(TTM) | 7.26 |
P/B Ratio | 2.36 |
Dividend Yield | 0.00% |
Industry P/E | 33.86 |
Book Value | 48.19 |
Debt to Equity | 0.82 |
Face Value | 10 |
Parent Organisation | Sotac Pharmaceuticals |
Managing Director | Mr. Sharadkumar Patel |
NSE Symbol | SOTAC |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 100.21 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.19 | ||
Emcure Pharmaceuticals | NA (0.00%) | 32.70 | ||
Wockhardt | NA (0.00%) | -176.41 |